Cargando…
Magnolol attenuates the locomotor impairment, cognitive deficit, and neuroinflammation in Alzheimer’s disease mice with brain insulin resistance via up-regulating miR-200c
In this study, we aimed to investigate the effect of Magnolol on Alzheimer’s disease (AD). After the model of streptozotocin-induced AD mice with brain insulin resistance was established, the mice were treated with Magnolol or miR-200c antagomiR. The abilities of ambulations, rearings, discriminatio...
Autores principales: | Chen, Ting, Shou, Lan, Guo, Xiaowen, Wei, Mingyang, Zheng, Hui, Tao, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805894/ https://www.ncbi.nlm.nih.gov/pubmed/34968163 http://dx.doi.org/10.1080/21655979.2021.2009975 |
Ejemplares similares
-
Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Xian, Yan-Fang, et al.
Publicado: (2020) -
Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice
por: Zhao, Ling, et al.
Publicado: (2017) -
Synthesis, anti-aging and mechanism of magnolol derivatives
por: Pang, Xinxin, et al.
Publicado: (2023) -
Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
por: Cai, Mudan, et al.
Publicado: (2019) -
CD200‐CD200R1 signaling pathway regulates neuroinflammation after stroke
por: Zhao, Shou‐cai, et al.
Publicado: (2020)